Impact of HIV-1 Vpr manipulation of the DNA repair enzyme UNG2 on B lymphocyte class switch recombination.
Patrick EldinSophie PéronAnastasia GalashevskayaNicolas Denis-LagacheMichel CognéGeir SlupphaugLaurence BriantPublished in: Journal of translational medicine (2020)
This work therefore opens up new perspectives to study alterations of the B-cell response by using Vpr as a specific CSR blocking tool. Moreover, our results raise the question of whether extracellular HIV-1 Vpr detected in some patients may manipulate the antibody diversification process that engineers an adapted response against pathogenic intruders and thereby contribute to the intrinsic B-cell humoral defect reported in infected patients.
Keyphrases
- dna repair
- antiretroviral therapy
- dna damage
- hiv positive
- hiv infected
- end stage renal disease
- hiv testing
- human immunodeficiency virus
- hepatitis c virus
- hiv aids
- ejection fraction
- chronic kidney disease
- newly diagnosed
- immune response
- men who have sex with men
- peritoneal dialysis
- dna damage response
- peripheral blood
- patient reported outcomes